ZAP327 signaling domain–driven chimeric antigen receptor generates robust and long-term antitumor immunity in mouse models

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1ZAP327 signaling domain–driven chimeric antigen receptor generates robust and long-term antitumor immunity in mouse models2025
2. 2Generation of antitumor chimeric antigen receptors incorporating T cell signaling motifs2024 · 3 citations
3. 3The impact of CD3ζ ITAM multiplicity and sequence on CAR T-cell survival and function2025 · 7 citations
4. 4Dissecting the role of CAR signaling architectures on T cell activation and persistence using pooled screening and single-cell sequencing2024 · 4 citations
5. 5Reprogramming CAR with cytokine signaling increases the efficacy of CAR-T cell therapy in solid tumour treatment and confers sustained immune memory2026 · 1 citations